Document Detail


Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum.
MedLine Citation:
PMID:  16003133     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has been associated with several metabolic conditions (MC) and secondary causes, but the relationship between insulin resistance (IR) and the underlying aetiology of NAFLD has not been extensively explored. OBJECTIVE: To determine the frequency of IR among NAFLD patients and to describe IR according to risk factors and histological findings of the disease. METHODOLOGY: A case-series study of 64 patients with clinical and histological diagnosis of NAFLD. IR was calculated by homeostasis model assessment (HOMA) and IR was considered when HOMA > or = 3. Histological grades of NAFLD were: stage 1, steatosis isolated; stage 2, steatosis and inflammation; stage 3, steatosis and ballooning degeneration; stage 4, steatosis and fibrosis and/or Mallory bodies. Fibrosis was graded 0-4 (cirrhosis). RESULTS: IR was found in 21 (33%) patients. Among those with IR, 16 patients (76%) had associated MC and five patients (24%) had exposure to petrochemicals. The mean value of HOMA varied from 3.5 in NAFLD associated with MC to 1.6 in patients with exposure to petrochemicals (P < 0.03). Waist circumference was the metabolic factor most strongly associated with IR (P < 0.005). Steatohepatitis (NASH) was observed in 54 (84.3%) cases. The HOMA mean value was significantly higher in patients with advanced fibrosis. CONCLUSIONS: IR occurred in 33% of the NAFLD patients, being more frequent among those with MC than among those with exposure to petrochemicals. The presence of IR in cases with advanced fibrosis suggests that it may influence the prognosis of NAFLD.
Authors:
Ana Cristina Guidorizzi de Siqueira; Helma P Cotrim; Raquel Rocha; Fernando M Carvalho; Luiz A R de Freitas; Danyella Barreto; Leandro Gouveia; Luciana Landeiro
Related Documents :
15540913 - Continuous-flow shunt for treatment of hydrocephalus due to lesions of the posterior fo...
18632533 - Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents...
9053473 - Gallium scans in the management of patients with hodgkin's disease: a study of 101 pati...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  17     ISSN:  0954-691X     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-07-08     Completed Date:  2005-12-29     Revised Date:  2009-10-16    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  837-41     Citation Subset:  IM    
Affiliation:
Curso de Pós-graduação em Medicina e Saúde, Faculdade de Medicina da Universidade Federal da Bahia, Brazil. anaguido@terra.com.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Chronic Disease
Fatty Liver / blood,  pathology,  physiopathology*
Female
Humans
Insulin Resistance / physiology*
Liver Cirrhosis / blood,  pathology,  physiopathology
Male
Metabolic Syndrome X / blood,  pathology,  physiopathology
Middle Aged
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum dis...
Next Document:  Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with c...